Canada Pharmaceutical Analytical Testing Outsourcing Market Analysis

Canada Pharmaceutical Analytical Testing Outsourcing Market Analysis


$ 3999

Canada Pharmaceutical Analytical Testing Outsourcing market is projected to grow from $xx Mn in 2022 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2022 - 2030. The market for Pharmaceutical analytical testing outsourcing is growing rapidly as a result of increase in the usage of pharmaceuticals and therapeutics requiring specialized manufacturing capabilities, rise in the presence of strict regulations and requirement of pertaining to the standards provided by the authorities, growth in modernization and innovations requiring reduction of operating costs of manufacturing and development, rise in the demand for biosimilars and biopharmaceutical products as well as for analytical drugs, increase in number of products in the pipeline and rise in the improved efficiency in testing, reduced cost, quicker & reliable results and rising research and development activities in the healthcare sector. Exova, Charles River Laboratories, Boston Analytical, West Pharmaceutical Services, Inc., Dalton Pharma Services, Merck KGaA, Cambrex Corporation, WuXi AppTec, Source BioScience, Ajinomoto Bio-Pharma, Catalent, Inc., Gateway Analytical, Alcami Corporation, Aztech Sciences Inc., Recro, and AptarGroup, Inc. are few companies in Pharmaceutical Analytical Testing Outsourcing.

ID: IN10CAPH365 CATEGORY: Pharmaceuticals GEOGRAPHY: Canada AUTHOR: Aneri Parekh

Buy Now

Canada Pharmaceutical Analytical Testing Outsourcing Market Analysis Summary

Canada Pharmaceutical Analytical Testing Outsourcing Market is valued at around $572.8 Mn in 2022 and is projected to reach $1110.6 Mn by 2030, exhibiting a CAGR of 8.63% during the forecast period 2023-2030.

Pharmaceutical analytical testing outsourcing is the constitution of services from the manufacturing, testing, and validating the pharmaceuticals and therapeutics. These services support method development and validation of pharmaceutical ingredients, Stability Testing, Impurity Analysis, Dissolution Testing, Microbiological Testing, Raw Material Testing, and Batch Release Testing. Cost Savings, Regulatory Compliance, and Technological Advancements are the main drivers. Exova, Charles River Laboratories, Boston Analytical, West Pharmaceutical Services, Inc., Dalton Pharma Services, Merck KGaA, Cambrex Corporation, WuXi AppTec, Source BioScience, Ajinomoto Bio-Pharma, Catalent, Inc., Gateway Analytical, Alcami Corporation, Aztech Sciences Inc., Recro, and AptarGroup, Inc. are few companies in Pharmaceutical Analytical Testing Outsourcing.

Market Dynamics

Market Growth Drivers

Increase in the usage of pharmaceuticals and therapeutics requiring specialized manufacturing capabilities, rise in the presence of strict regulations and requirements of on the standards provided by the authorities, growth in modernization and innovations requiring reduction of operating costs of manufacturing and development, rise in the demand for biosimilars and biopharmaceutical products as well as for analytical drugs, increase in number of products in the pipeline and rise in the improved efficiency in testing, reduced cost, quicker & reliable results and rising research and development activities in the healthcare sector. All these act as market growth drivers.

Market Restraints

Increase in the number of unstable outsourced manufacturing organizations

The increase in the concerns regarding privacy/theft of confidential data of manufacturing pharmaceuticals is the major market growth restraint.

Competitive Landscape

Key Players

  • Exova
  • Charles River Laboratories
  • Boston Analytical
  • West Pharmaceutical Services, Inc.
  • Dalton Pharma Services
  • Merck KGaA
  • Cambrex Corporation
  • WuXi AppTec
  • Source BioScience
  • Ajinomoto Bio-Pharma
  • Catalent, Inc.
  • Gateway Analytical
  • Alcami Corporation
  • Aztech Sciences Inc.
  • Recro
  • AptarGroup, Inc.

1. Executive Summary
1.1 Disease Overview
1.2 Global Scenario
1.3 Country Overview
1.4 Healthcare Scenario in Country
1.5 Patient Journey
1.6 Health Insurance Coverage in Country
1.7 Active Pharmaceutical Ingredient (API)
1.8 Recent Developments in the Country

2. Market Size and Forecasting
2.1 Epidemiology of Disease
2.2 Market Size (With Excel & Methodology)
2.3 Market Segmentation (Check all Segments in Segmentation Section)

3. Market Dynamics
3.1 Market Drivers
3.2 Market Restraints

4. Competitive Landscape
4.1 Major Market Share

4.2 Key Company Profile (Check all Companies in the Summary Section)

4.2.1 Company
4.2.1.1 Overview
4.2.1.2 Product Applications and Services
4.2.1.3 Recent Developments
4.2.1.4 Partnerships Ecosystem
4.2.1.5 Financials (Based on Availability)

5. Reimbursement Scenario
5.1 Reimbursement Regulation
5.2 Reimbursement Process for Diagnosis
5.3 Reimbursement Process for Treatment

6. Methodology and Scope

Canada Pharmaceutical Analytical Testing Outsourcing Market Segmentation

By Service Type

  • Bioanalytical Testing
  • Clinical
  • Non-clinical
  • Method Development & Validation

  • Extraction & Leachable
  • Impurity Method
  • Technical Consulting
  • Others
  • Stability Testing
  • Drug Substance
  • Stability Indicating Method Validation
  • Accelerated Stability Testing
  • Photostability Testing
  • Others

By Product Type

  • Raw Materials
  • Finished Product and
  • Active Pharmaceutical Ingredients

By End Users

  • Pharmaceutical & Biopharmaceutical Companies
  • Biotechnology Industry

Methodology for Database Creation

Our database offers a comprehensive list of healthcare centers, meticulously curated to provide detailed information on a wide range of specialties and services. It includes top-tier hospitals, clinics, and diagnostic facilities across 30 countries and 24 specialties, ensuring users can find the healthcare services they need.​

Additionally, we provide a comprehensive list of Key Opinion Leaders (KOLs) based on your requirements. Our curated list captures various crucial aspects of the KOLs, offering more than just general information. Whether you're looking to boost brand awareness, drive engagement, or launch a new product, our extensive list of KOLs ensures you have the right experts by your side. Covering 30 countries and 36 specialties, our database guarantees access to the best KOLs in the healthcare industry, supporting strategic decisions and enhancing your initiatives.

How Do We Get It?

Our database is created and maintained through a combination of secondary and primary research methodologies.

1. Secondary Research

With many years of experience in the healthcare field, we have our own rich proprietary data from various past projects. This historical data serves as the foundation for our database. Our continuous process of gathering data involves:

  • Analyzing historical proprietary data collected from multiple projects.
  • Regularly updating our existing data sets with new findings and trends.
  • Ensuring data consistency and accuracy through rigorous validation processes.

With extensive experience in the field, we have developed a proprietary GenAI-based technology that is uniquely tailored to our organization. This advanced technology enables us to scan a wide array of relevant information sources across the internet. Our data-gathering process includes:

  • Searching through academic conferences, published research, citations, and social media platforms
  • Collecting and compiling diverse data to build a comprehensive and detailed database
  • Continuously updating our database with new information to ensure its relevance and accuracy

2. Primary Research

To complement and validate our secondary data, we engage in primary research through local tie-ups and partnerships. This process involves:

  • Collaborating with local healthcare providers, hospitals, and clinics to gather real-time data.
  • Conducting surveys, interviews, and field studies to collect fresh data directly from the source.
  • Continuously refreshing our database to ensure that the information remains current and reliable.
  • Validating secondary data through cross-referencing with primary data to ensure accuracy and relevance.

Combining Secondary and Primary Research

By integrating both secondary and primary research methodologies, we ensure that our database is comprehensive, accurate, and up-to-date. The combined process involves:

  • Merging historical data from secondary research with real-time data from primary research.
  • Conducting thorough data validation and cleansing to remove inconsistencies and errors.
  • Organizing data into a structured format that is easily accessible and usable for various applications.
  • Continuously monitoring and updating the database to reflect the latest developments and trends in the healthcare field.

Through this meticulous process, we create a final database tailored to each region and domain within the healthcare industry. This approach ensures that our clients receive reliable and relevant data, empowering them to make informed decisions and drive innovation in their respective fields.

To request a free sample copy of this report, please complete the form below.


We value your inquiry and offer free customization with every report to fulfil your exact research needs.


Last updated on: 27 February 2024
Updated by: Bhanu Pratap Singh

Related reports (by category)


Related reports (by geography)


subscribe to our newsletter
up